EUROPE VETERINARY MEDICINES MARKET FORECAST 2019-2028

The Europe veterinary medicines market is anticipated to project a CAGR of 4.46%, over the forecast period of 2019 to 2028. The region’s market growth is attributed to the rise in pet ownership, and extensive scientific innovation, research, and development across the animal health sector.

Europe Veterinary Medicines Market

To learn more about this report, request a free sample copy

The Europe veterinary medicines market growth is evaluated by assessing the countries such as the United Kingdom, Russia, Belgium, Germany, Poland, Italy, France, and the rest of Europe. The United Kingdom’s veterinary medicines market observes a growing trend, owing to the surging awareness concerning animal health issues. The increasing incidence of numerous medical complications, in livestock and companion animals, also contributes to market growth. The United Kingdom’s Veterinary Vaccinology Network (VVN) is establishing efforts to introduce innovative developments, in addition to the latest tools and technology for meeting the country’s veterinary vaccinology needs.

The United Kingdom is among the rapidly growing veterinary medicines markets, mainly due to diverse veterinary research activities conducted across the country. This has led to the development of innovative animal products, thereby playing an essential role in garnering significant market share. Such research activities have also built a knowledge base in the industry for developing new products for efficient pet health. Thus, these factors are expected to drive market growth, over the forecast years.

Boehringer Ingelheim Animal Health GmbH, headquartered in Germany, primarily develops, produces, and distributes pharmaceutical products. The company provides prescription medicines in areas such as, oncology, cardiovascular, respiratory, diabetes, central nervous system, etc., in addition to animal health products, like biological and natural care products for companion animals, cattle, swine, and horses. In September 2020, the enterprise collaborated with Click Therapeutics to develop and commercialize CT-155.

 

TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. SCOPE OF STUDY
    3. METHODOLOGY
    4. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
  3. MARKET DYNAMICS
    1. MARKET DEFINITION
    2.    KEY DRIVERS
      1. SURGING LIVESTOCK POPULATION
      2. INCREASING ANIMAL HEALTHCARE EXPENDITURE
      3. GROWING PET OWNERSHIP
      4. RISE IN THE PREVALENCE OF SEVERAL DISEASES IN ANIMALS
    3.    KEY RESTRAINTS
      1. STRINGENT REGULATIONS WITH RESPECT TO THE VETERINARY MEDICINES
      2. SIDE EFFECTS ASSOCIATED WITH VETERINARY VACCINES ON HUMAN AND ANIMAL HEALTH
      3. HIGH COST OF VACCINATIONS
  4. KEY ANALYTICS
    1.    PORTER'S FIVE FORCE ANALYSIS
      1. THREAT OF NEW ENTRY
      2. THREAT OF SUBSTITUTION
      3. BUYER'S POWER
      4. SUPPLIER'S POWER
      5. COMPETITIVE RIVALRY
    2. VALUE CHAIN ANALYSIS
    3. IMPACT OF COVID-19 ON VETERINARY MEDICINES MARKET
    4. OPPORTUNITY MATRIX
    5. VENDOR LANDSCAPE
    6. KEY INVESTMENT INSIGHTS
  5. MARKET BY ANIMAL TYPE
    1. COMPANION ANIMALS
    2. LIVESTOCK ANIMALS
  6. MARKET BY DISTRIBUTION CHANNEL
    1. RETAIL VETERINARY PHARMACIES
    2. VETERINARY HOSPITAL PHARMACIES
  7. MARKET BY ROUTE OF ADMINISTRATION
    1. PARENTERAL ROUTE
    2. ORAL ROUTE
    3. TOPICAL ROUTE
  8. MARKET BY PRODUCT
    1. DRUGS
    2. VACCINES
    3. MEDICATED FEED ADDITIVES
  9. GEOGRAPHICAL ANALYSIS
    1.    EUROPE
      1. GERMANY
      2. FRANCE
      3. THE UNITED KINGDOM
      4. ITALY
      5. RUSSIA
      6. POLAND
      7. BELGIUM
      8. REST OF EUROPE
  10. COMPANY PROFILES
    1. ARCHER DANIELS MIDLAND
    2. BIOGENESIS BAGO SA
    3. BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH
    4. CEVA SANTE ANIMALE
    5. DECHRA PHARMACEUTICALS PLC
    6. ELANCO
    7. EVONIK INDUSTRIES AG (RAG STIFTUNG)
    8. HESTER BIOSCIENCES LIMITED
    9. INDIAN IMMUNOLOGICALS LIMITED
    10. KINDRED BIOSCIENCES
    11. MERCK & CO
    12. NEOGEN CORPORATION
    13. VETOQUINOL (SOPARFIN SCA)
    14. VIRBAC SA
    15. ZOETIS
LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – VETERINARY MEDICINES

TABLE 2: EUROPE VETERINARY MEDICINES MARKET, BY ANIMAL TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 3: EUROPE VETERINARY MEDICINES MARKET, BY ANIMAL TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 4: EUROPE VETERINARY MEDICINES MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 5: EUROPE VETERINARY MEDICINES MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 6: EUROPE VETERINARY MEDICINES MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 7: EUROPE VETERINARY MEDICINES MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 8: EUROPE VETERINARY MEDICINES MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 9: EUROPE VETERINARY MEDICINES MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)

TABLE 10: EUROPE VETERINARY MEDICINES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 11: EUROPE VETERINARY MEDICINES MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

FIGURE 2: IMPACT OF COVID-19 ON VETERINARY MEDICINES MARKET

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: EUROPE VETERINARY MEDICINES MARKET, BY ANIMAL TYPE, IN 2019

FIGURE 6: EUROPE VETERINARY MEDICINES MARKET, BY COMPANION ANIMALS, 2019-2028 (IN $ MILLION)

FIGURE 7: EUROPE VETERINARY MEDICINES MARKET, BY LIVESTOCK ANIMALS, 2019-2028 (IN $ MILLION)

FIGURE 8: EUROPE VETERINARY MEDICINES MARKET, BY DISTRIBUTION CHANNEL, IN 2019

FIGURE 9: EUROPE VETERINARY MEDICINES MARKET, BY RETAIL VETERINARY PHARMACIES, 2019-2028 (IN $ MILLION)

FIGURE 10: EUROPE VETERINARY MEDICINES MARKET, BY VETERINARY HOSPITAL PHARMACIES, 2019-2028 (IN $ MILLION)

FIGURE 11: EUROPE VETERINARY MEDICINES MARKET, BY ROUTE OF ADMINISTRATION, IN 2019

FIGURE 12: EUROPE VETERINARY MEDICINES MARKET, BY PARENTERAL ROUTE, 2019-2028 (IN $ MILLION)

FIGURE 13: EUROPE VETERINARY MEDICINES MARKET, BY ORAL ROUTE, 2019-2028 (IN $ MILLION)

FIGURE 14: EUROPE VETERINARY MEDICINES MARKET, BY TOPICAL ROUTE, 2019-2028 (IN $ MILLION)

FIGURE 15: EUROPE VETERINARY MEDICINES MARKET, BY PRODUCT, IN 2019

FIGURE 16: EUROPE VETERINARY MEDICINES MARKET, BY DRUGS, 2019-2028 (IN $ MILLION)

FIGURE 17: EUROPE VETERINARY MEDICINES MARKET, BY VACCINES, 2019-2028 (IN $ MILLION)

FIGURE 18: EUROPE VETERINARY MEDICINES MARKET, BY MEDICATED FEED ADDITIVES, 2019-2028 (IN $ MILLION)

FIGURE 19: EUROPE VETERINARY MEDICINES MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 20: GERMANY VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 21: FRANCE VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 22: THE UNITED KINGDOM VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 23: ITALY VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 24: RUSSIA VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 25: POLAND VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 26: BELGIUM VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 27: REST OF EUROPE VETERINARY MEDICINES MARKET, 2019-2028 (IN $ MILLION)

Request For A Free Sample